PHARMAC’s implementation of Trans-Pacific Partnership provisions and other amendments to application processes

5 September 2016 - PHARMAC is seeking feedback on our proposed approach to addressing New Zealand’s obligations under the Trans-Pacific Partnership (TPP) Agreement.

PHARMAC receives applications from a wide range of people asking us to fund particular medicines and in the future we expect to be asked about funding particular medical devices.

New Zealand has obligations under the TPP, relating to Transparency and Procedural Fairness for Pharmaceutical Products and Medical Devices, which are to be implemented by PHARMAC.

Read PHARMAC Consultation

Michael Wonder

Posted by:

Michael Wonder